Market Research Logo

Illumina Inc (ILMN) - Product Pipeline Analysis, 2018 Update

Summary

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Illumina Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Illumina Inc Company Overview
Illumina Inc Company Snapshot
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc – Pipeline Analysis Overview
Business Description
Illumina Inc - Key Facts
Illumina Inc - Major Products and Services
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Pipeline Products Overview
Albumin Multiplex Assay
Albumin Multiplex Assay Product Overview
Companion Diagnostic Test - Oncology
Companion Diagnostic Test - Oncology Product Overview
Diagnostic Test - Nasopharyngeal Cancer
Diagnostic Test - Nasopharyngeal Cancer Product Overview
InfiniumDx CytoSNP-12 Assay
InfiniumDx CytoSNP-12 Assay Product Overview
Lab-On-A-Chip
Lab-On-A-Chip Product Overview
LSD-100 Lysosomal Storage Enzyme Analyzer
LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview
MRSA Screening Test
MRSA Screening Test Product Overview
NGS Diagnostic System
NGS Diagnostic System Product Overview
NGS-Based Transplant Diagnostic Assay
NGS-Based Transplant Diagnostic Assay Product Overview
Pan-Cancer Screening Test
Pan-Cancer Screening Test Product Overview
Pan-Cancer Screening Test Clinical Trial
Point-Of-Care Diagnostic Device- HIV
Point-Of-Care Diagnostic Device- HIV Product Overview
Portable Benchtop Analyzer - Viral Load Assay
Portable Benchtop Analyzer - Viral Load Assay Product Overview
STAT-Seq Test
STAT-Seq Test Product Overview
TruSight Tumor 170
TruSight Tumor 170 Product Overview
Verifi Prenatal Test
Verifi Prenatal Test Product Overview
Verifi Prenatal Test Clinical Trial
Illumina Inc - Key Competitors
Illumina Inc - Key Employees
Illumina Inc - Key Employee Biographies
Illumina Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Illumina Inc, Recent Developments
May 09, 2018: ECRI Institute Reveals Important Differences in Prenatal Genetic Tests
May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners
Apr 24, 2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
Apr 16, 2018: Almac Diagnostics Validates Illumina TruSight Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
Mar 12, 2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
Jan 30, 2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
Jan 15, 2018: HCA Virginia Joins Sarah Cannon Early Breast Cancer Detection Study
Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
Jan 08, 2018: Illumina Launches iSeq 100 Sequencing System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Indication
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc, Key Facts
Illumina Inc, Major Products and Services
Illumina Inc Number of Pipeline Products by Development Stage
Illumina Inc Pipeline Products Summary by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Ongoing Clinical Trials Summary
Albumin Multiplex Assay - Product Status
Albumin Multiplex Assay - Product Description
Companion Diagnostic Test - Oncology - Product Status
Companion Diagnostic Test - Oncology - Product Description
Diagnostic Test - Nasopharyngeal Cancer - Product Status
Diagnostic Test - Nasopharyngeal Cancer - Product Description
InfiniumDx CytoSNP-12 Assay - Product Status
InfiniumDx CytoSNP-12 Assay - Product Description
Lab-On-A-Chip - Product Status
Lab-On-A-Chip - Product Description
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
MRSA Screening Test - Product Status
MRSA Screening Test - Product Description
NGS Diagnostic System - Product Status
NGS Diagnostic System - Product Description
NGS-Based Transplant Diagnostic Assay - Product Status
NGS-Based Transplant Diagnostic Assay - Product Description
Pan-Cancer Screening Test - Product Status
Pan-Cancer Screening Test - Product Description
Pan-Cancer Screening Test - Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection: The STRIVE Study
Pan-Cancer Screening Test - The Circulating Cell-free Genome Atlas Study
Point-Of-Care Diagnostic Device- HIV - Product Status
Point-Of-Care Diagnostic Device- HIV - Product Description
Portable Benchtop Analyzer - Viral Load Assay - Product Status
Portable Benchtop Analyzer - Viral Load Assay - Product Description
STAT-Seq Test - Product Status
STAT-Seq Test - Product Description
TruSight Tumor 170 - Product Status
TruSight Tumor 170 - Product Description
Verifi Prenatal Test - Product Status
Verifi Prenatal Test - Product Description
Verifi Prenatal Test - Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Glossary
List of Figures
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report